Implications of Low-Titer MOG Antibodies

Affiliations

¹ Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: MLEVY11@mgh.harvard.edu.
² The Hospital for Sick Children, University of Toronto, Toronto, M5G 1 × 8, Ontario, Canada.
³ Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK.
⁴ John Hunter Hospital Department of Neurology, Newcastle, 2305, Australia.
⁵ Queen Mary University of London, Barts and the London School of Medicine and Dentistry, Centre for Neuroscience and Trauma, London, United Kingdom.

Editorial

Michael Levy et al. Mult Scler Relat Disord. 2022 Mar.

. 2022 Mar:59:103746.

doi: 10.1016/j.msard.2022.103746. Epub 2022 Mar 17.

¹ Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: MLEVY11@mgh.harvard.edu.
² The Hospital for Sick Children, University of Toronto, Toronto, M5G 1 × 8, Ontario, Canada.
³ Queen Mary University of London, Barts and The London School of Medicine and Dentistry, London, UK.
⁴ John Hunter Hospital Department of Neurology, Newcastle, 2305, Australia.
⁵ Queen Mary University of London, Barts and the London School of Medicine and Dentistry, Centre for Neuroscience and Trauma, London, United Kingdom.

No abstract available

Keywords: MOG; MOG antibody disease; MOGAD; low-titer.

Publication types